1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kawulka, K.E.
Sprules, T.
McKay, R.T.
Mercier, P.
Diaper, C.M.
Zuber, P.
Vederas, J.C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C4 H9 N O3
119.119
D-allothreonine
D-peptide linking
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C9 H11 N O2
165.189
D-PHENYLALANINE
D-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
43
3385
3395
10.1021/bi0359527
15035610
Structure of subtilisin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives
2004
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
125
4726
4727
10.1021/ja029654t
Structure of subtilisin A, an antimicrobial peptide from Bacillus subtilis with unusual posttranslational modifications linking cysteine sulfurs to alpha-carbons of phenylalanine and threonine
2003
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
x-ray
1
1.0
3426.917
Subtilisin A
1
nat
polymer
Antilisterial bacteriocin subtilisin
no
yes
NKGCATCSIGAACLVDGPIPDFEIAGA(2TL)GL(DPN)GLWG
NKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Bacillus
sample
1423
Bacillus subtilis
JH642
repository
Initial release
Version format compliance
Version format compliance
Structure summary
1
0
2004-06-22
1
1
2008-04-29
1
2
2011-07-13
1
3
2011-10-05
RCSB
Y
RCSB
2003-07-04
REL
REL
structures with the lowest energy
50
8
3D_15N-separated_NOESY
3D_13C-separated_NOESY
4D_13C/15N-separated_NOESY
HNHA
288
K
301 NOE-derived distance constraints and 20 dihedral angle restraints were used to calculate the structures.
dynamic annealing
1
lowest energy
SubA
collection
VNMR
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., Bax, A.J.'
processing
NMRPipe
2.2
Johnson, B.A., Blevins, R.A.J.
data analysis
NMRView
5.0
Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J., Rice, L.M., Simonson, T., Warren, G.L.
structure solution
CNS
1.1
Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J., Rice, L.M., Simonson, T., Warren, G.L.
refinement
CNS
1.1
500
Varian
INOVA
800
Varian
INOVA
ASN
1
n
1
ASN
1
A
LYS
2
n
2
LYS
2
A
GLY
3
n
3
GLY
3
A
CYS
4
n
4
CYS
4
A
ALA
5
n
5
ALA
5
A
THR
6
n
6
THR
6
A
CYS
7
n
7
CYS
7
A
SER
8
n
8
SER
8
A
ILE
9
n
9
ILE
9
A
GLY
10
n
10
GLY
10
A
ALA
11
n
11
ALA
11
A
ALA
12
n
12
ALA
12
A
CYS
13
n
13
CYS
13
A
LEU
14
n
14
LEU
14
A
VAL
15
n
15
VAL
15
A
ASP
16
n
16
ASP
16
A
GLY
17
n
17
GLY
17
A
PRO
18
n
18
PRO
18
A
ILE
19
n
19
ILE
19
A
PRO
20
n
20
PRO
20
A
ASP
21
n
21
ASP
21
A
PHE
22
n
22
PHE
22
A
GLU
23
n
23
GLU
23
A
ILE
24
n
24
ILE
24
A
ALA
25
n
25
ALA
25
A
GLY
26
n
26
GLY
26
A
ALA
27
n
27
ALA
27
A
THR
28
n
28
2TL
28
A
GLY
29
n
29
GLY
29
A
LEU
30
n
30
LEU
30
A
PHE
31
n
31
DPN
31
A
GLY
32
n
32
GLY
32
A
LEU
33
n
33
LEU
33
A
TRP
34
n
34
TRP
34
A
GLY
35
n
35
GLY
35
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
N
O
ASN
GLY
1
35
2.05
2
A
A
N
O
ASN
GLY
1
35
1.80
3
A
A
H1
C
ASN
GLY
1
35
1.50
3
A
A
N
O
ASN
GLY
1
35
2.07
4
A
A
H1
C
ASN
GLY
1
35
1.24
4
A
A
N
O
ASN
GLY
1
35
2.17
5
A
A
H1
C
ASN
GLY
1
35
1.48
5
A
A
N
O
ASN
GLY
1
35
2.17
6
A
A
H1
C
ASN
GLY
1
35
1.39
7
A
A
H1
C
ASN
GLY
1
35
1.53
7
A
A
N
O
ASN
GLY
1
35
2.10
8
A
A
H1
C
ASN
GLY
1
35
1.57
8
A
A
N
O
ASN
GLY
1
35
2.17
1
A
CYS
4
-76.59
49.90
1
A
CYS
7
-154.78
46.13
1
A
ILE
9
-44.57
-71.57
1
A
ALA
12
-164.24
89.87
1
A
ILE
19
85.98
32.12
1
A
ASP
21
77.52
119.02
1
A
PHE
22
15.52
56.87
1
A
2TL
28
-45.12
-28.85
2
A
LYS
2
-82.70
-81.37
2
A
CYS
7
-155.02
65.92
2
A
ILE
9
-59.82
102.03
2
A
ALA
12
-158.83
88.15
2
A
ILE
19
86.01
35.02
2
A
ASP
21
78.61
109.58
2
A
PHE
22
32.20
55.29
2
A
2TL
28
-54.55
-165.59
2
A
DPN
31
-59.42
-19.93
3
A
CYS
4
-156.97
26.29
3
A
THR
6
-78.23
41.93
3
A
CYS
7
174.83
39.62
3
A
ILE
9
-52.25
104.52
3
A
ALA
12
-160.01
80.08
3
A
ILE
19
86.05
37.71
3
A
ASP
21
76.13
109.31
3
A
PHE
22
31.24
58.00
3
A
GLU
23
-93.64
41.08
3
A
2TL
28
-149.15
19.45
4
A
CYS
7
-154.89
65.83
4
A
ALA
11
-50.84
106.46
4
A
ALA
12
-167.13
28.70
4
A
ASP
16
-99.17
31.66
4
A
ILE
19
86.21
59.82
4
A
ASP
21
63.27
117.01
4
A
PHE
22
-24.78
80.06
4
A
ILE
24
-88.89
-70.76
5
A
LYS
2
-83.15
41.51
5
A
CYS
4
45.75
26.70
5
A
CYS
7
-155.27
49.78
5
A
ALA
12
-159.73
57.15
5
A
ASP
16
-97.60
30.32
5
A
ILE
19
86.03
58.83
5
A
PRO
20
-94.19
38.82
5
A
ASP
21
48.32
109.19
5
A
PHE
22
-14.67
83.09
5
A
2TL
28
-36.56
-41.24
5
A
TRP
34
-131.09
-76.93
6
A
THR
6
-78.21
49.70
6
A
CYS
7
-178.26
44.38
6
A
ILE
9
-58.37
-74.86
6
A
ALA
11
-54.63
107.33
6
A
ALA
12
-163.97
79.28
6
A
ILE
19
86.21
43.00
6
A
PRO
20
-56.36
-90.34
6
A
ASP
21
154.52
82.50
6
A
ILE
24
-89.05
-77.70
7
A
CYS
4
37.73
-161.80
7
A
ALA
5
-69.84
-176.09
7
A
CYS
7
-153.52
34.65
7
A
ALA
11
-69.26
64.47
7
A
ALA
12
-170.59
75.19
7
A
ILE
19
85.77
34.45
7
A
ASP
21
77.51
113.55
7
A
PHE
22
15.97
57.64
7
A
2TL
28
-44.81
-23.35
7
A
TRP
34
-107.33
-77.34
8
A
CYS
4
45.60
29.32
8
A
CYS
7
-154.48
43.81
8
A
ALA
11
-81.19
44.62
8
A
ALA
12
-173.21
95.11
8
A
ILE
19
86.17
33.68
8
A
ASP
21
76.39
105.96
8
A
PHE
22
29.30
53.60
8
A
ILE
24
-89.26
-76.65
8
A
2TL
28
-51.92
-16.43
8
A
TRP
34
-130.17
-76.31
Subtilisin A
Structure of Subtilisin A
1
N
N
A
2TL
28
A
2TL
28
HELX_P
A
GLY
35
A
GLY
35
1
1
8
covale
1.333
A
ALA
27
A
C
ALA
27
1_555
A
2TL
28
A
N
2TL
28
1_555
covale
1.331
A
2TL
28
A
C
2TL
28
1_555
A
GLY
29
A
N
GLY
29
1_555
covale
1.331
A
LEU
30
A
C
LEU
30
1_555
A
DPN
31
A
N
DPN
31
1_555
covale
1.330
A
DPN
31
A
C
DPN
31
1_555
A
GLY
32
A
N
GLY
32
1_555
covale
1.329
A
ASN
1
A
N
ASN
1
1_555
A
GLY
35
A
C
GLY
35
1_555
covale
1.770
A
CYS
7
A
SG
CYS
7
1_555
A
2TL
28
A
CA
2TL
28
1_555
covale
1.775
A
CYS
13
A
SG
CYS
13
1_555
A
PHE
22
A
CA
PHE
22
1_555
covale
1.776
A
CYS
4
A
SG
CYS
4
1_555
A
DPN
31
A
CA
DPN
31
1_555
ANTIMICROBIAL PROTEIN
thioether bridge, cyclic peptide, bacteriocin, ANTIMICROBIAL PROTEIN
SBOA_BACSU
UNP
1
9
O07623
NKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG
9
43
1PXQ
1
35
O07623
A
1
1
35
BINDING SITE FOR RESIDUE DPN A 31
Software
8
A
ASN
1
A
ASN
1
8
1_555
A
CYS
4
A
CYS
4
8
1_555
A
2TL
28
A
2TL
28
8
1_555
A
GLY
29
A
GLY
29
8
1_555
A
LEU
30
A
LEU
30
8
1_555
A
GLY
32
A
GLY
32
8
1_555
A
LEU
33
A
LEU
33
8
1_555
A
GLY
35
A
GLY
35
8
1_555
1
P 1